IMSTEM BIOTECHNOLOGY INC has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Canada and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are TRIMED BIOTECH GMBH, SECARNA PHARMACEUTICALS GMBH & CO KG and SYNVOLUX IP BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | Hong Kong | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 | |
#7 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wang Xiaofang | 17 |
#2 | Xu Ren-He | 15 |
#3 | Xu Renhe | 2 |
Publication | Filing date | Title |
---|---|---|
CN104487568A | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof | |
CA2876499A1 | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof |